News

2023

• Early results on the A 055 POR trial

  19 December 2023
  Vaccine Well Tolerated and Demonstrated Immunogenicity But Did Not Provide Protection Against TB Recurrence; Participants Being Informed; Further Analysis Continues

  ---

• POR-TB Last participant last visit

  18 April 2023

  ---

2022

• POR TB annual meeting

  15 November 2022
  The Prevention of Tuberculosis Recurrence Consortium (POR TB) held its annual meeting virtually on 15 November 2022. The meeting included presentations from work package leaders and clinical trial sites in South Africa and Tanzania, where the study i...

  ---

2019

• POR A-055 vaccinations initiated

  18 December 2019
  EDCTP funded clinical trial testing new tuberculosis (TB) vaccine initiates vaccinations

  ---

• Annual Meeting 2019

  10 May 2019
  The second Annual meeting took place in Cape Town on April 8th and 9th 2019

  ---

2018

• Kick-Off Meeting 

  15 March 2018

  ---

2017

• Project start

  1 November 2017

  ---